Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension, Primary, 3”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Large-scale testing (Phase 3)WithdrawnNCT02999906
What this trial is testing

Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics
Large-scale testing (Phase 3)Enrolling By InvitationNCT03683186
What this trial is testing

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

Who this might be right for
PAHPulmonary HypertensionPulmonary Arterial Hypertension+8 more
United Therapeutics 1,000
Not applicableEnded earlyNCT04008550
What this trial is testing

Prognostic Impact of the Evolution of PAH 3 Months After TAVI (HTP-TAVI)

Who this might be right for
Aortic Valve StenosisPulmonary Hypertension
University Hospital, Rouen 101
Large-scale testing (Phase 3)Ended earlyNCT01210443
What this trial is testing

Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

Who this might be right for
Hypertension, Pulmonary
Pfizer 2
Not applicableStudy completedNCT01468545
What this trial is testing

Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System

Who this might be right for
Pulmonary Arterial Hypertension
Bayer 38
Testing effectiveness (Phase 2)Study completedNCT05224531
What this trial is testing

Effect of CS1 in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Cereno Scientific AB 25
Large-scale testing (Phase 3)Study completedNCT03904693
What this trial is testing

Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Actelion 187
Post-approval studies (Phase 4)Study completedNCT03344159
What this trial is testing

Spironolactone Therapy in Chronic Stable Right HF Trial

Who this might be right for
Chronic Right-Sided Heart FailurePulmonary Arterial HypertensionPulmonary Hypertension, Primary, 2+3 more
Ottawa Heart Institute Research Corporation 15
Testing effectiveness (Phase 2)Study completedNCT01265888
What this trial is testing

Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.

Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary Fibrosis
Geno LLC 31
Large-scale testing (Phase 3)Study completedNCT05818137
What this trial is testing

Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 46
Large-scale testing (Phase 3)Ended earlyNCT05036135
What this trial is testing

AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Aerovate Therapeutics 202
Large-scale testing (Phase 3)Ended earlyNCT04084678
What this trial is testing

Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH

Who this might be right for
PAHPulmonary HypertensionHypertension+8 more
United Therapeutics 10
Large-scale testing (Phase 3)Study completedNCT05167825
What this trial is testing

Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Janssen Pharmaceutical K.K. 7
Large-scale testing (Phase 3)Study completedNCT04811092
What this trial is testing

Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13)

Who this might be right for
Pulmonary Arterial Hypertension
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 321
Testing effectiveness (Phase 2)Looking for participantsNCT06846554
What this trial is testing

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Apollo Therapeutics Ltd 48
Testing effectiveness (Phase 2)Study completedNCT00454558
What this trial is testing

An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension

Who this might be right for
Hypertension, Pulmonary
Bayer 75
Large-scale testing (Phase 3)Study completedNCT04896008
What this trial is testing

Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)

Who this might be right for
Pulmonary Arterial Hypertension
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 173
Testing effectiveness (Phase 2)Looking for participantsNCT04778046
What this trial is testing

Pulmonary Hypertension SOLAR

Who this might be right for
Interstitial Lung DiseaseCOPDPulmonary Arterial Hypertension
Bastiaan Driehuys 30
Large-scale testing (Phase 3)Study completedNCT03399604
What this trial is testing

Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil

Who this might be right for
Primary Pulmonary Hypertension
Liquidia Technologies, Inc. 121
Large-scale testing (Phase 3)Active Not RecruitingNCT04691154
What this trial is testing

Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension Due to Lung Diseases
Liquidia Technologies, Inc. 28
Load More Results